Emergent BioSolutions (EBS) Other Non Operating Income (2011 - 2026)

Emergent BioSolutions' Other Non Operating Income history runs 16 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 80.06% year-over-year to $13.9 million in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 108.59% decrease from a year earlier, with the FY2025 full-year figure at -$12.2 million, down 202.52% from the prior year.
• Other Non Operating Income advanced to $13.9 million in Q1 2026 per EBS's latest filing, from -$13.8 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $69.7 million in Q1 2025 and bottomed at -$13.8 million in Q4 2025.
• The 5-year median for Other Non Operating Income is -$2.7 million (2024), against an average of $4.2 million.
• Across the five-year window, Other Non Operating Income tumbled 458.33% in 2022 and surged 2150.0% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $6.7 million in 2022, then grew by 26.87% to $8.5 million in 2023, then tumbled by 145.88% to -$3.9 million in 2024, then sank by 253.85% to -$13.8 million in 2025, then jumped by 200.72% to $13.9 million in 2026.
• Per Business Quant, the three latest EBS Other Non Operating Income figures stand at $13.9 million (Q1 2026), -$13.8 million (Q4 2025), and -$3.7 million (Q3 2025).